BTG obtained U.S. marketing and distribution rights to Wellstat Therapeutics’ investigational drug uridine triacetate (PN401, formerly known as vistonuridine), for the treatment of accidental ...

One company value investors might notice is B2Gold Corp (BTG). BTG is currently sporting a Zacks Rank of #2 (Buy) and an A for Value.

--BTG Specialty Pharmaceuticals, a division of Boston Scientific, today announced the European Medicines Agency has accepted for review a Marketing Authorisation Application for Voraxaze ®. BTG ...

Does B2Gold (BTG) have what it takes to be a top stock pick for momentum investors? Let's find out.

B2Gold (BTG) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with ...

Brazilian lenders BTG Pactual, Bradesco and Santander Brasil are among those most exposed to debt of Americanas SA , analysts' estimates showed on Monday, after the retailer obtained an injunction ...

Banco BTG Pactual SA on Monday became the latest Brazilian lender to be affected by bad credit provisions due to what it called a "specific, widely publicized event," likely referring to the ...

B2Gold Corp. (NYSEAMERICAN:BTG) is among the 10 Most Undervalued Stocks to Buy for Under $5. Its share price has soared nearly 56% year-to-date, with investors rallying behind the stock amid ...

In trading on Friday, shares of B2Gold Corp (Symbol: BTG) entered into oversold territory, changing hands as low as $2.65 per share. We define oversold territory using the Relative Strength Index ...

Explore B2Gold analyst ratings and price targets (AMEX:BTG) on Benzinga. Stay updated on expert opinions and forecasts for BTG stock.

BTG Specialty Pharmaceuticals is seeking marketing authorization of Voraxaze ® for the treatment of adults and children (from 28 days of age) at risk of methotrexate toxicity due to delayed ...